1. Home
  2. AVDL vs RSKD Comparison

AVDL vs RSKD Comparison

Compare AVDL & RSKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVDL
  • RSKD
  • Stock Information
  • Founded
  • AVDL 2015
  • RSKD 2012
  • Country
  • AVDL Ireland
  • RSKD United States
  • Employees
  • AVDL N/A
  • RSKD N/A
  • Industry
  • AVDL Biotechnology: Pharmaceutical Preparations
  • RSKD EDP Services
  • Sector
  • AVDL Health Care
  • RSKD Technology
  • Exchange
  • AVDL Nasdaq
  • RSKD Nasdaq
  • Market Cap
  • AVDL 861.4M
  • RSKD 790.1M
  • IPO Year
  • AVDL 1996
  • RSKD 2021
  • Fundamental
  • Price
  • AVDL $10.04
  • RSKD $5.10
  • Analyst Decision
  • AVDL Strong Buy
  • RSKD Hold
  • Analyst Count
  • AVDL 6
  • RSKD 8
  • Target Price
  • AVDL $18.17
  • RSKD $6.03
  • AVG Volume (30 Days)
  • AVDL 1.6M
  • RSKD 464.8K
  • Earning Date
  • AVDL 08-07-2025
  • RSKD 08-13-2025
  • Dividend Yield
  • AVDL N/A
  • RSKD N/A
  • EPS Growth
  • AVDL N/A
  • RSKD N/A
  • EPS
  • AVDL N/A
  • RSKD N/A
  • Revenue
  • AVDL $194,450,000.00
  • RSKD $333,495,000.00
  • Revenue This Year
  • AVDL $56.88
  • RSKD $5.92
  • Revenue Next Year
  • AVDL $29.81
  • RSKD $9.38
  • P/E Ratio
  • AVDL N/A
  • RSKD N/A
  • Revenue Growth
  • AVDL 252.64
  • RSKD 9.30
  • 52 Week Low
  • AVDL $6.38
  • RSKD $3.94
  • 52 Week High
  • AVDL $17.30
  • RSKD $6.56
  • Technical
  • Relative Strength Index (RSI)
  • AVDL 63.41
  • RSKD 48.95
  • Support Level
  • AVDL $8.74
  • RSKD $4.82
  • Resistance Level
  • AVDL $9.56
  • RSKD $5.27
  • Average True Range (ATR)
  • AVDL 0.40
  • RSKD 0.14
  • MACD
  • AVDL 0.08
  • RSKD 0.01
  • Stochastic Oscillator
  • AVDL 98.70
  • RSKD 35.14

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

About RSKD Riskified Ltd.

Riskified Ltd has built a next-generation eCommerce risk management platform that allows online merchants to create trusted relationships with their consumers. It generates revenue by granting merchants access to its eCommerce risk management platform and reviewing and approving eCommerce transactions for legitimacy. Its merchants include some of the ecommerce brands including Wayfair, Lastminute.com, SHEIN, and Macy's. Its merchants operate in a variety of verticals, including Payments, Money Transfer & Crypto, Tickets & Travel, Electronics, Home, Fashion & Luxury Goods, General Retail and Food. The company derived maximum revenue from Israel.

Share on Social Networks: